Related Articles
PROGNOSTIC FACTORS IN PURGED MARROW FROM PATIENTS WITH NEUROBLASTOMA RECEIVING MYELOABLATIVE TREATMENT - TUMOR-CELL NUMBER, N-MYC PROTEIN, N-MYC GENE AMPLIFICATION AND RATE OF HEMATOLOGIC RECOVERY
Treatment of high-risk solid tumors of childhood with myeloablative chemotherapy and autologous stem cell transplantation
GENERATION OF PROGENITOR-CELL PRECURSORS IN LONG-TERM BONE-MARROW CULTURES AFTER MARROW PURGING WITH ETHER LIPIDS
Impact of reorganized interfacility transfer on emergency obstetric care in Nara prefecture, Japan
Effect of low molecular weight heparin (Certoparin) versus unfractionated heparin on cancer survival following breast and pelvic cancer surgery: A prospective randomized double-blind trial.